{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:05:59Z","timestamp":1790928359175,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007190","name":"Unilever","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tox.2025.154364","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:29:55Z","timestamp":1764779395000},"page":"154364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Characterising a HepaRG liver microphysiological system for individual bile acid secretion and chemical induced disruptions"],"prefix":"10.1016","volume":"520","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-8671","authenticated-orcid":false,"given":"Katharina S.","family":"Nitsche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Bouwmeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2025.154364_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/CEG.S360563","article-title":"Functional, diagnostic and therapeutic aspects of bile","volume":"15","author":"Ahmed","year":"2022","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.tox.2025.154364_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13036-019-0148-5","article-title":"Human three-dimensional in vitro model of hepatic zonation to predict zonal hepatotoxicity","volume":"13","author":"Ahn","year":"2019","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.tox.2025.154364_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1404938","article-title":"Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4","volume":"15","author":"Albadry","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.tox.2025.154364_bib4","doi-asserted-by":"crossref","DOI":"10.1039\/C9LC00768G","article-title":"Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry","author":"Baudy","year":"2020","journal-title":"Lab Chip"},{"key":"10.1016\/j.tox.2025.154364_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/toxsci\/kfx289","article-title":"Comparison of hepatic 2D sandwich cultures and 3d spheroids for long-term toxicity applications: a multicenter study","volume":"162","author":"Bell","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154364_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.comtox.2017.10.001","article-title":"Ab initio chemical safety assessment: a workflow based on exposure considerations and non-animal methods","volume":"4","author":"Berggren","year":"2017","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.tox.2025.154364_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152667","article-title":"A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate\u00ae","volume":"450","author":"Bircsak","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2025.154364_bib8","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ad818a","article-title":"A microvascularized in vitro liver model for disease modeling and drug discovery","volume":"17","author":"Bonanini","year":"2025","journal-title":"Biofabrication"},{"key":"10.1016\/j.tox.2025.154364_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.toxlet.2022.06.004","article-title":"Hepatic bile acid synthesis and secretion: comparison of in vitro methods","volume":"365","author":"de Bruijn","year":"2022","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2025.154364_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229106","article-title":"A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction","volume":"15","author":"Bulutoglu","year":"2020","journal-title":"PLOS One"},{"key":"10.1016\/j.tox.2025.154364_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112588","article-title":"Polyphenol effects on cholesterol metabolism via bile acid biosynthesis, CYP7A1: a review","author":"Chambers","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.tox.2025.154364_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.taap.2009.06.022","article-title":"Altered integrity and decreased expression of hepatocyte tight junctions in rifampicin-induced cholestasis in mice","volume":"240","author":"Chen","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2025.154364_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.taap.2018.02.005","article-title":"Aryl hydrocarbon receptor (AhR) mediated short-term effects of 2,3,7,8-tetrachlorodibenzo- p -dioxin (TCDD) on bile acid homeostasis in mice","volume":"343","author":"Csanaky","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.tox.2025.154364_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.732929","article-title":"Liver zonation \u2013 revisiting old questions with new technologies","volume":"12","author":"Cunningham","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tox.2025.154364_bib15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/hep.30918","article-title":"A bile duct-on-a-chip with organ-level functions","volume":"71","author":"Du","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2025.154364_bib16","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1021\/acssensors.0c01524","article-title":"A membrane-free liver-gut-on-chip platform for the assessment on dysregulated mechanisms of cholesterol and bile acid metabolism induced by PM2.5","volume":"5","author":"Duan","year":"2020","journal-title":"ACS Sens."},{"key":"10.1016\/j.tox.2025.154364_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89710-6","article-title":"Comparison of gene expression and biotransformation activity of HepaRG cells under static and dynamic culture conditions","volume":"11","author":"Duivenvoorde","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154364_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1152\/physiol.00036.2016","article-title":"Modeling physiological events in 2D vs. 3D cell culture","volume":"32","author":"Duval","year":"2017","journal-title":"Physiology"},{"key":"10.1016\/j.tox.2025.154364_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-bioeng-060418-052305","article-title":"Challenges and opportunities in the design of liver-on-chip microdevices","volume":"21","author":"Ehrlich","year":"2019","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.tox.2025.154364_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-022-00209-1","article-title":"Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology","volume":"2","author":"Ewart","year":"2022","journal-title":"Commun. Med."},{"key":"10.1016\/j.tox.2025.154364_bib21","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1038\/s41598-017-05656-8","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-elicited effects on bile acid homeostasis: alterations in biosynthesis, enterohepatic circulation, and microbial metabolism","volume":"7","author":"Fader","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154364_bib22","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9420-5_1","article-title":"Mechanisms of drug-induced cholestasis","author":"Gijbels","year":"2019"},{"key":"10.1016\/j.tox.2025.154364_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.949033","article-title":"Bile acids in immunity: bidirectional mediators between the host and the microbiota","author":"Godlewska","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tox.2025.154364_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrm1858","article-title":"Capturing complex 3D tissue physiology in vitro","author":"Griffith","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tox.2025.154364_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.livres.2022.08.006","article-title":"Efficacy and safety of low-dose rifampicin in patients with benign intrahepatic cholestasis","volume":"6","author":"Guo","year":"2022","journal-title":"Liver Res."},{"key":"10.1016\/j.tox.2025.154364_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41551-019-0498-9","article-title":"Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips","volume":"4","author":"Herland","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tox.2025.154364_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1389200216666151103115454","article-title":"Bile acids in physiology, pathology and pharmacology","volume":"17","author":"J.G. Marin","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tox.2025.154364_bib28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/term.2802","article-title":"Differentiation of the human liver progenitor cell line (HepaRG) on a microfluidic-based biochip","volume":"13","author":"Jang","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.tox.2025.154364_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10544-018-0300-x","article-title":"Study of melatonin-mediated effects on various hepatic inflammatory responses stimulated by IL-6 in a new HepG2-on-a-chip platform","volume":"20","author":"Jang","year":"2018","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.tox.2025.154364_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax5516","article-title":"Reproducing human and cross-species drug toxicities using a Liver-Chip","volume":"11","author":"Jang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tox.2025.154364_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-40004-z","article-title":"Evaluation of drug-induced liver toxicity of trovafloxacin and levofloxacin in a human microphysiological liver model","volume":"13","author":"Kaden","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154364_bib32","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1038\/s41598-018-27179-6","article-title":"Metabolic patterning on a chip: towards in vitro liver zonation of primary rat and human hepatocytes","volume":"8","author":"Kang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154364_bib33","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1021\/pr049756d","article-title":"Plasma protein level changes in waste incineration workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"4","author":"Kang","year":"2005","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.tox.2025.154364_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105533","article-title":"Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes","volume":"87","author":"Kastrinou Lampou","year":"2023","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2025.154364_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105464","article-title":"Analysis of reproducibility and robustness of OrganoPlate\u00ae 2-lane 96, a liver microphysiological system for studies of pharmacokinetics and toxicological assessment of drugs","volume":"85","author":"Kato","year":"2022","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2025.154364_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","article-title":"In vitro models for the study of liver biology and diseases: advances and limitations","volume":"15","author":"Kaur","year":"2023","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2025.154364_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrgentox.2024.503762","article-title":"Liver-on-chip model and application in predictive genotoxicity and mutagenicity of drugs","volume":"896","author":"Kopp","year":"2024","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen"},{"key":"10.1016\/j.tox.2025.154364_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/bdd.2333","article-title":"Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells","volume":"43","author":"Le V\u00e9e","year":"2022","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.tox.2025.154364_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.11.026","article-title":"Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro","volume":"78","author":"Leite","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.tox.2025.154364_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/toxsci\/kfs232","article-title":"Three-dimensional HepaRG model as an attractive tool for toxicity testing","volume":"130","author":"Leite","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154364_bib41","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1089\/ten.tea.2018.0020","article-title":"A fluidic culture platform for spatially patterned cell growth, differentiation, and cocultures","volume":"24","author":"Lembong","year":"2018","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.tox.2025.154364_bib42","article-title":"A guide to the organ-on-a-chip","volume":"2","author":"Leung","year":"2022","journal-title":"Nat. Rev. Methods Prim."},{"key":"10.1016\/j.tox.2025.154364_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering10101195","article-title":"Reproducibility and robustness of a liver microphysiological system physioMimix LC12 under varying culture conditions and cell type combinations","volume":"10","author":"Lim","year":"2023","journal-title":"Bioengineering"},{"key":"10.1016\/j.tox.2025.154364_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vascn.2010.04.013","article-title":"HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro","volume":"63","author":"L\u00fcbberstedt","year":"2011","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.tox.2025.154364_bib45","doi-asserted-by":"crossref","DOI":"10.1115\/1.4051119","article-title":"Optimization of oxygen delivery within hydrogels","volume":"143","author":"Mavris","year":"2021","journal-title":"J. Biomech. Eng."},{"key":"10.1016\/j.tox.2025.154364_bib46","article-title":"Liver-on-chips for drug discovery and development","volume":"27","author":"Mehta","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.tox.2025.154364_bib47","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1039\/D2LC00307D","article-title":"Liver organ-on-chip models for toxicity studies and risk assessment","volume":"22","author":"Messelmani","year":"2022","journal-title":"Lab Chip"},{"key":"10.1016\/j.tox.2025.154364_bib48","unstructured":"Mimetas B.V., 2022. OrganoPlate \u00ae 3-lane 40 [WWW Document]. URL \u3008https:\/\/www.mimetas.com\/files\/products\/OrganoPlat%203-lane%2040\/202_Flyer_OrganoPlat%203-lane%2040%20product%20specifications.pdf\u3009 (accessed 11.29.22)."},{"key":"10.1016\/j.tox.2025.154364_bib49","unstructured":"Mummery, C., van Meer, B., van den Eijnden \u2013 van Raaij, J., van de Graaf, A., 2020. Mini Organs-on-Chips [WWW Document]. URL \u3008https:\/\/www.biomaatschappij.nl\/wp-content\/uploads\/2020\/11\/BWM-Mini-Organs-on-Chips.pdf\u3009."},{"key":"10.1016\/j.tox.2025.154364_bib50","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.R069286","article-title":"The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases","author":"Nagahashi","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tox.2025.154364_bib51","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.5c00554","article-title":"Comparative analysis of species-specific hepatocyte function and drug effects in a liver microphysiological system physiomimix LC12 and 96-well plates","author":"Negi","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.tox.2025.154364_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.810478","article-title":"Accurate evaluation of hepatocyte metabolisms on a noble oxygen-permeable material with low sorption characteristics","volume":"4","author":"Nishikawa","year":"2022","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.tox.2025.154364_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2025.1649393","article-title":"Alternatives to animal-derived extracellular matrix hydrogels? An explorative study with HepaRG cells in animal-free hydrogels under static and dynamic culture conditions","volume":"7","author":"Nitsche","year":"2025","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.tox.2025.154364_bib54","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00204-022-03234-0","article-title":"Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review","volume":"96","author":"Nitsche","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2025.154364_bib55","article-title":"Human liver microphysiological system for assessing drug-induced liver toxicity in vitro","author":"Novac","year":"2022","journal-title":"J. Vis. Exp. 2022"},{"key":"10.1016\/j.tox.2025.154364_bib56","unstructured":"Organ-on-Chip Market Size, Share & Analysis Report, 2033 [WWW Document], n.d. URL \u3008https:\/\/www.marketdataforecast.com\/market-reports\/organ-on-chip-market\u3009 (accessed 7.8.25)."},{"key":"10.1016\/j.tox.2025.154364_bib57","doi-asserted-by":"crossref","DOI":"10.14573\/altex.2205081","article-title":"Technical framework for enabling high-quality measurements in new approach methodologies (NAMs)","author":"Petersen","year":"2022","journal-title":"ALTEX"},{"key":"10.1016\/j.tox.2025.154364_bib58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.freeradbiomed.2017.10.003","article-title":"Limitations of oxygen delivery to cells in culture: an underappreciated problem in basic and translational research","volume":"113","author":"Place","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tox.2025.154364_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biomaterials.2015.08.043","article-title":"A microfluidically perfused three dimensional human liver model","volume":"71","author":"Rennert","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.tox.2025.154364_bib60","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1158\/0008-5472.CAN-17-0988","article-title":"Keratin 19 expression in hepatocellular carcinoma is regulated by fibroblast-derived HGF via a MET-ERK1\/2-AP1 and SP1 axis","volume":"78","author":"Rhee","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2025.154364_bib61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cpt.1458","article-title":"Liver microphysiological systems for predicting and evaluating drug effects","volume":"106","author":"Ribeiro","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2025.154364_bib62","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1124\/dmd.113.054205","article-title":"Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump","volume":"42","author":"Rodrigues","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2025.154364_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152651","article-title":"Analysis of reproducibility and robustness of a human microfluidic four-cell liver acinus microphysiology system (LAMPS)","volume":"448","author":"Sakolish","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2025.154364_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00524","article-title":"Induction of in vitro metabolic zonation in primary hepatocytes requires both near-physiological oxygen concentration and flux","volume":"8","author":"Scheidecker","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tox.2025.154364_bib65","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/toxsci\/kfv155","article-title":"Cellular accumulation and toxic effects of bile acids in cyclosporine a-treated hepaRG hepatocytes","volume":"147","author":"Sharanek","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154364_bib66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/03602532.2022.2039688","article-title":"Through a glass, darkly? HepaRG and HepG2 cells as models of human phase I drug metabolism","volume":"54","author":"Stanley","year":"2022","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tox.2025.154364_bib67","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1194\/jlr.RA119000307","article-title":"Of mice and men: murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism","volume":"61","author":"Straniero","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tox.2025.154364_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120904","article-title":"A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoids","volume":"275","author":"Teng","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.tox.2025.154364_bib69","article-title":"Species differences in bile acids I. Plasma and urine bile acid composition","volume":"38","author":"Thakare","year":"2018","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2025.154364_bib70","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1021\/acsbiomaterials.7b00417","article-title":"Liver-kidney-on-chip to study toxicity of drug metabolites","volume":"4","author":"Theobald","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.tox.2025.154364_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105422","article-title":"Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition","volume":"136","author":"Vilas-Boas","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.tox.2025.154364_bib72","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00204-018-2201-4","article-title":"In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist","volume":"92","author":"Vinken","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2025.154364_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109010","article-title":"A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro","volume":"116","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tox.2025.154364_bib74","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1039\/C8LC00869H","article-title":"In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system","volume":"18","author":"Wang","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.tox.2025.154364_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44198-0","article-title":"A model of hepatic steatosis with declined viability and function in a liver-organ-on-a-chip","volume":"13","author":"Wiriyakulsit","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154364_bib76","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.3748\/wjg.v12.i22.3553","article-title":"Bile acid interactions with cholangiocytes","volume":"12","author":"Xia","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tox.2025.154364_bib77","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X25003233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X25003233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:40:25Z","timestamp":1773877225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X25003233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":77,"alternative-id":["S0300483X25003233"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2025.154364","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterising a HepaRG liver microphysiological system for individual bile acid secretion and chemical induced disruptions","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2025.154364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"154364"}}